Pharmascience Canada yakatanga mushonga wayo mutsva wegeneric pms-LURASIDONE pamusika weCanada uye ichave iripo nemutengo wakaderera kune varwere.
Pms-LURASIDONE inoratidzwa semonotherapy yekutonga kwekuratidzwa kweschizophrenia muvakuru uye muvechiri kuyaruka (15-17 yemakore). Iyo inoratidzirwawo kune acute manejimendi ekuora mwoyo episodhi ane chekuita nebipolar disorder muvakuru nevechiri kuyaruka (13-17 makore ezera). Kunyangwe pms-LURASIDONE isingarape aya matambudziko, inogona kubatsira kubata zviratidzo.
Ichi chigadzirwa, chiri cheboka remishonga inonzi atypical antipsychotics, ichagoverwa mumasimba akawanda, akadai se20 mg, 40 mg, 60 mg, 80 mg uye 120 mg.
Inopa kuchengetedzwa kwakafanana uye chimiro chekushanda sechigadzirwa-zita remhando, mahwendefa aya e-pms-LURASIDONE generic bioequivalent to Latuda ®.
ZVOKUBVA MUNYAYA INO:
- Pms-LURASIDONE inoratidzwa se monotherapy yekutonga kwekuratidzwa kweschizophrenia muvakuru uye muvechiri kuyaruka (15-17 yemakore).
- Inopa kuchengetedzwa kwakafanana uye chimiro chekushanda sechigadzirwa-zita remhando, mahwendefa aya e-pms-LURASIDONE generic bioequivalent to Latuda ®.
- Inoratidzirwawo kune acute manejimendi ezvekuora mwoyo episodhi ane chekuita nebipolar disorder muvakuru nevechiri kuyaruka (13-17 makore ezera).
